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Abstract 
Tramadol and paracetamol are analgesic drugs that are often combined and made in the form of 
extemporaneously prepared capsules dosage form to treat moderate to severe pain management. This 
study aims to determine the quality of prescribed medication of extemporaneously prepared tramadol 
and paracetamol capsules combination taken from a private hospital in Semarang covering weight 
uniformity, moisture content, disintegration, and content uniformity. This type of research is a 
descriptive observational cross-sectional design. Samples were taken using simple random sampling 
at a pharmaceutical installation in a private hospital in Semarang. The observation result from four 
types of testing was compared against the standard values of each test’s parameter listed in the 
Indonesian Pharmacopoeia V. The results are, samples meet the weight uniformity test with an 
acceptance value of 7.34%; meet the moisture content test with an average moisture content of 
2.647% for the first day and 3.04% for the seventh day; meet the disintegration test with a breakdown 
time of fewer than 15 minutes; and did not meet the uniformity test with acceptance value of 34.06% 
for paracetamol and 34.30% for tramadol. It can be concluded that the prescribed medication of 
extemporaneously prepared capsule samples derived from a private hospital in Semarang can fulfill 
the standard values listed in the Indonesian Pharmacopoeia V except for the content uniformity test. 
 








Extemporaneous preparation is 
preparation for the order or prescription from a 
doctor or dentist, from individually selected 
starting materials it is dispensed immediately 
after preparation and not kept in stock. 
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Extemporaneous dispensing is still being used 
up until today because there are circumstances 
in which there is no licensed medicine that fully 
meets the clinical needs of patients. In these 
circumstances, it is sometimes necessary for the 
pharmacist to extemporaneously prepare a 
limited quantity of a custom-made medicine for 
a specific patient [1]. 
Whilst extemporaneous preparation do 
not go through the same stages with licensed 
medicine from the pharmaceutical industry, 
extemporaneously prepared medicines must be 
confirmed to have proper quality thus can 
provide a good outcome for patient therapy. 
Standard quality that must be fulfilled from 
extemporaneous preparation must achieve 
suitable physical, chemical, and microbiological 
stability [1]. One of much physical qualities from 
extemporaneous solid oral dosage form 
formulation is content uniformity as it can 
provide an overview that the active ingredients 
within the prepared formulation are 
homogeneous [2]. 
Several studies regarding physical quality 
from solid extemporaneous formulation has 
been published only 4 out of 10 pharmacies in 
Yogyakarta can fulfill the weight and content 
uniformity quality requirement for prescribed 
paracetamol pulverize [3], hydrochlorothiazide 
pulverize in Yogyakarta were not able to fulfil 
the weight and content uniformity quality 
parameter but were able to fulfil the moisture 
content quality parameter [4],  diltiazem 
pulverize in X hospital were not able to fulfil the 
weight and content uniformity quality 
parameter but were able to fulfil the moisture 
content quality parameter [5]. 
Some example on why the quality from 
extemporaneous solid oral dosage form 
formulation fails to be accomplished are error 
that occurs in the extemporaneous preparation 
process, such as some medicine powders are left 
behind in the mortar that is being used to crush 
and mix the medicine and limitations in visual 
observation, precision, skill, and time whilst 
preparing the extemporaneous formulation [6] 
[7]. The emerging consequence of an error while 
preparing the extemporaneous preparation for 
instance labeling, mistake while picking up the 
starting materials, and input on dispensing 
equipment may take away the patient’s life [8] 
[9] [10] [11].  
Pharmaceutical installation at a private 
hospital in Semarang dispense lots of tramadol 
and paracetamol capsules combination 
extemporaneous formulation although licensed 
medicine on the market is commercially 
available. This compounding practice still 
accessible for the destitute patient and this 
dispensed capsules are prescribed to substitute 
for brand name drugs such as Acetram®, 
Analtram®, Dotramol®, and Sincronik® since 
this medicine can cost more expensive. 
Tramadol and paracetamol synergistically work 
as a barrier in the central nervous system and 
peripheral nervous system. Tramadol 25 mg 
and paracetamol 250 mg capsules combination 
is being used in hospitals for the treatment of 
moderate to severe pain management [12]. 
Medicines are required to possess a certain 
quality before given to the patient. The quality 
of extemporaneously prepared capsules dosage 
form must meet with the standard values listed 
in the Indonesian Pharmacopoeia V, such as 
weight uniformity, content uniformity, moisture 
content, disintegration, and dissolution. 
Dissolution testing is technically can not be 
done since the precise quantity of the active 
ingredients from the extemporaneously 
prepared capsule samples is unavailable [13]. 
A pharmacist must ensure that patients 
receive medicines of the appropriate quality to 
safeguard the patient quality of life and safety by 
monitoring extemporaneous preparation 
activities in the hospital [14]. Nevertheless, this 
study discovers that dispensing activities are 
left unsupervised by the pharmacist, so the 
quality of the dispensed medicine is 
questionable [15]. Therefore, it is necessary to 
study the quality of extemporaneously prepared 
capsules dosage form comprises weight 
uniformity, content uniformity, moisture 
content, and disintegration.  
 
2 Materials and Methods  
This type of research is a descriptive 
observational cross-sectional design. Samples 
were taken using simple random sampling at a 
pharmaceutical installation in a private hospital 
in Semarang, Central Java.  
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2.1 Materials 
Working standards of tramadol (Ferron 
Industries, Indonesia) and paracetamol (Dexa 
Medika Industries, Indonesia) it is certified to 
contain 99.2% tramadol and 99.3% 
paracetamol on a dry weight basis.  Methanol 
gradient grade for liquid chromatography (E. 
Merck®, Indonesia), aquabidest was obtained 
from Water Purification System Easy Pure II RF, 
extemporaneously prepared capsules dosage 
form of tramadol 12.5 mg and paracetamol 125 
mg taken from a private hospital in Semarang. 
2.2 Samples  
The total number of samples was derived 
from the literature study of each test parameter. 
It was concluded that 30 samples were required  
with 10 samples for weight uniformity test, 9 
samples for the moisture content test, 3 samples 
for disintegration test, 6 samples for content 
uniformity test, and 2 extra samples. All samples 
are handpick using a simple random sampling 
technique, pharmaceutical installation in the 
hospital is required to hand over 3 batches 
(@10 capsules) of samples (Figure 1) from the 





Figure 1. Extemporaneously prepared tramadol and 
paracetamol capsules combination taken from a private 





Figure 2. Prescribed medication of extemporaneously 
prepared tramadol and paracetamol capsules combination 
taken from a private hospital in Semarang.  
2.3 Weight uniformity test 
Weight uniformity test is performed using 
analytical balance Ohaus® (PAJ1003, USA) with 
0.1 mg precision limit (max 120 g, min 0.001 g). 
The test is carried out on 10 samples of each 
batch to calculate the acceptance value which 
then will be compared with the maximum 
allowed acceptance value (L1%). Weight 
uniformity is determined by calculating the 
weight of each sample, perceive the theoretical 
quantity of active ingredients, reference value, 
acceptance constant referring to the literature 
[13]. 
2.4 Moisture content test 
Moisture content test is performed using a 
moisture analyzer (KERN MLS®, Germany). As 
much as 3 capsules are each taken from 3 
batches of dispensed samples, then 9 samples 
are divided into 2 to be tested on day 1 and day 
7. The powder from the capsule is placed into 
the analyzer then sealed and left until the value 
of moisture content appeared [13]. 
2.5 Disintegration test 
Disintegration test is performed using 
disintegration tester (Shanghai Develop 
Machinery BJ-2®, China). The amount of 
samples required is 3 capsules, each is placed 
inside the tube tester and pressured by the disc. 
The machine is left running for 15 minutes with 
37oC water as a medium as we observe the 
samples begin to change [13]. 
2.6 Content uniformity test 
2.6.1 Instrumentation and 
chromatographic conditions 
The HPLC system (Shimadzu® LC-2010HT, 
Japan) which consisted of an ACE C18 column 
(250×4.6 mm i.d., 5 μm particle size), pump with 
manual sampler injector programmed at 10 µl 
capacity per injection, UV/Vis detector, data 
were processed with a computer (Hewlett 
Packard®, Indonesia), the mobile phase 
consisted of 40:60 (v/v); methanol: aquabidest, 
the flow rate was set to 0.6 mL/min and UV 
detection was carried out at 271 nm in room 
temperature [16]. 
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2.6.2 Standard solutions and calibration 
graphs  
Stock standard solution containing 
tramadol (1000 µg/mL) and paracetamol  
(1000 µg/mL) was prepared by dissolving 10.0 
mg of tramadol and 10.0 mg of paracetamol in 
10.0 mL volumetric flask with the mobile phase 
consisted of 40:60 (v/v); methanol: aquabidest. 
This was further diluted to obtain working 
standard solutions in a concentration range of 1-
19 µg/mL (i.e. 1; 4; 7; 10; 16; and 19μg/mL) for 
tramadol and 20-80 μg/mL (i.e 20; 30; 40; 50; 
70; and 80 µg/mL) for paracetamol. A constant 
volume of 10 µL standard solution with the 
chosen concentration ratio was injected and 
chromatographed under the above-mentioned 
conditions. The peak areas were plotted against 
the corresponding concentrations to obtain the 
calibration graphs [16]. 
2.6.3 Sample preparation 
As much as 6 samples capsules were 
divided into two part of equal amount, part one  
was analyzed on day 1 and part two were 
analyzed on day 7. Each sample part is taken and 
transferred into 25 mL volumetric flask with 
methanol and aquabidest (40:60) mobile phase. 
From the volumetric flask, 10,0 µL solution is 
diluted in 1,0 mL microtube with the mobile 
phase. This solution was homogeneously 
shaken and filtered through a 0.45 μm millipore 
filter then transferred to HPLC vials and 
sonicated for 10 min. A constant 10 µL volume 
of sample solution was injected under the 
above-mentioned conditions [16]. 
2.6.4 Results analysis 
Data from weight uniformity test, moisture 
content test, disintegration test, and content 
uniformity test are compared with standard 
values listed in the Indonesian Pharmacopoeia 
V. Standard values for capsule weight 
uniformity and content uniformity are the 
amounts of acceptance value is no more than 
15,0 of  L1% value. The standard value for 
capsule moisture content is less than 5 % for 
magnesium stearate and cellulose-containing 
powder. The standard disintegration time for 
capsule is the length of time for the dosage form 
to disintegrate or equal to 15 minutes.  
 
3 Results and Discussion 
3.1 Weight Uniformity test 
Weight uniformity test aims to discover 
the uniformity degree of active ingredient 
within medicinal preparation using the weight 
of each sample capsule. Weight uniformity test 
can be implemented if the samples fulfill the 
required condition that is containing 25 mg or 
more of active ingredient comprising 25% or 
more by weight of the dosage unit. The obtained 
result has a range of 0.3874 to 0.4832 gram 
whilst the acceptance value is 7.34%, these 
results show that the extemporaneously 
prepared capsule samples meet with the quality 
conditions of weight uniformity test since the 
sample acceptance value is smaller than the 
maximum allowed acceptance value (L1%) that 
is 15.0% [13]. 
3.2 Moisture Content test 
Moisture content test is performed by 
comparing the powder weight before and after 
being dried. The purpose of this test is to 
examine the amount of water inside the 
capsule’s powder. The moisture content result 
attained from day 1 have a range of 2.315–
3.524% with a mean value of 2.647% and day 7 
have a range of 2.632–3.571% with a mean 
value of 3.04%. These results show that the 
extemporaneously prepared capsule’s powder 
meets with the quality conditions of a good 
moisture content since the results is under 5%, 
with storage conditions carried out in 
accordance with the storage instructions given 
by the hospital pharmacist to the patient which 
is to store inside a medicine box at room 
temperature, protected from direct sunlight, 
and silica gel is also given inside the medicine 
secondary package [13] [17]. Although the 
obtained result fell under the maximum 
standard limit quality in general, there was an 
increase of moisture content after the storage 
period. This increase is influenced by the active 
ingredient, namely, tramadol. Tramadol is a 
chemical compound that is formulated in a salt 
form to increase its solubility in water, which 
results in tramadol’s susceptible character to 
absorb humidity through the capsule shell 
causing the extemporaneously prepared 
capsule’s powder moisture content to rise after 
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storage [18]. Another influence comes from 
excipient ingredient within extemporaneous 
dosage form formulation since some excipient 
possesses certain characteristics that can 
absorb humidity more easily than the active 
ingredient hence increasing the moisture 
content of the extemporaneous dosage form 
formulation. Therefore, during the 
extemporaneous preparation process excipient 
ingredient must be selected while considering 
the physical and chemical properties of the 
active ingredient for example the stability of the 
active ingredient such as hygroscopicity, 
oxidation, hydrolysis [19]. 
3.3 Disintegration test 
Disintegration test objective is to observe 
the duration for capsules to thoroughly 
disintegrate, it can be seen visibly that only a 
soft mass without a core left inside the 
disintegration tester. Table 1 shows that the 
extemporaneously prepared capsule sample 
falls within the standard quality requirement 
for extemporaneous solid oral dosage form 
formulation which is under 15 minutes to 




Table 1 Disintegration test observation result 
Time Observation Result 
3 minutes Samples disintegrates 
9 minutes Capsule shell remains 
12 minutes Unclear, not obvious 




3.4 Content uniformity test 
Content uniformity test is carried out for 
extemporaneous solid oral dosage form 
formulation which contains more than one 
active ingredient to provide a clearer view of its 
degree of uniformity by determining the amount 
of each sample’s active ingredient. This study 
use reversed-phase HPLC method to analyze the 
content of active ingredient from the 
extemporaneous samples capsule formulation, 
the results are then used to calculate the 
sample’s acceptance value which is determined 
by individual weight contents of the capsule, 
active ingredient content of each capsule, mean 
of weight contents of the capsule, capsule 
weight content deviation, and a constant [13]. 
Reversed-phase HPLC is widely used for  drug 
analysis method because of its sensitivity, short 
analysis time, and reliability [20]. Table 2 show 
that the acceptance value of tramadol is 34,30% 
and 34,06% for paracetamol, these results 
shows that the extemporaneously prepared 
capsule samples do not fulfill the quality 
conditions of content uniformity test since the 
sample acceptance value is above the maximum 
allowed acceptance value (L1%) that is 15,0%. 
In other words, the active ingredients within 
extemporaneously prepared capsule samples 
are not evenly spread or distributed as a 
consequence of incorrect and improper samples 
dispensing process carried out by the hospital’s 
pharmaceutical installation, especially during 




It can be concluded that weight uniformity 
test, moisture content test, and disintegration 
test from the extemporaneously prepared 
capsule samples derived from a private hospital 
in Semarang can fulfill the standard values listed 
in the Indonesian Pharmacopoeia V except for 










C1 72.68 106.93 
C2 95.92 86.48 
C3 78.07 62.62 
C4 98.24 81.34 
C5 102.39 86.67 
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